Chronic Total Occlusion Crossing With the Ocelot System - CONNECT II

Inclusion Criteria: * Patient is willing and able to provide informed consent * Patient is willing and able to comply with the study protocol * Patient is \> 18 years old * Patient has peripheral arterial disease requiring revascularization as evidenced by CTA, MRA or angiography * Patient has an occluded femoropopliteal artery that is 99-100% stenosed and is ≥ 1 cm and ≤ 30 cm in length by visual estimate * Target vessel is ≥ 3.0 mm in diameter * Patient has Rutherford Classification of 2-5 * Lesion is recalcitrant to guidewire crossing Exclusion Criteria: * Patient has a known sensitivity or allergy to contrast materials that cannot be adequately pre-treated * Patient has a known sensitivity or allergy to aspirin, heparin or anti-platelet medications * Patient is pregnant or lactating * Patient has a co-existing disease or medical condition contraindicating percutaneous intervention * Target vessel is severely calcified as evidenced by angiography * Target lesion is in a bypass graft * Target lesion is in a stent (i.e., in-stent restenosis) * Patient has had a procedure on the target limb within 7 days * Patient has had a procedure on the target limb within the past 30 days and is unstable * Patient has a planned surgical or interventional procedure within 30 days after the study procedure * Patient is simultaneously participating in an investigational device study for treatment of peripheral vascular disease * Patient has a planned amputation of the target limb * Patient has a history of bleeding diathesis, coagulopathy or will refuse blood transfusion in cases of emergency